LRTX — Lirum Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual cashflow statement for Lirum Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | PROSPECTUS/A |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.027 | -1.92 | -2.2 |
| Non-Cash Items | 0.025 | — | — |
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.002 | 1.61 | -0.041 |
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Cash from Operating Activities | 0 | -0.306 | -2.24 |
| Other Investing Cash Flow Items | — | 0 | 0 |
| Other Investing Cash Flow | |||
| Cash from Investing Activities | — | 0 | 0 |
| Financing Cash Flow Items | 0 | -0.02 | -0.01 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 0 | 0.48 | 6.08 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0 | 0.174 | 3.83 |